FAMILIAL ADENOMATOUS POLYPOSIS
Clinical trials for FAMILIAL ADENOMATOUS POLYPOSIS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL ADENOMATOUS POLYPOSIS trials appear
Sign up with your email to follow new studies for FAMILIAL ADENOMATOUS POLYPOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a liver drug tame polyps in rare gut condition?
Disease control TerminatedThis study tested whether obeticholic acid, a drug already used for liver disease, can safely reduce the number of polyps in the small bowel and colon in people with familial adenomatous polyposis (FAP). FAP is a rare genetic condition that greatly raises the risk of intestinal c…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Study checks if stopping a drug made polyps grow faster
Knowledge-focused TerminatedThis study reviewed medical records of 42 people with familial adenomatous polyposis (FAP) who had previously taken the drug erlotinib. Researchers wanted to see how quickly the disease progressed after the drug was stopped. The goal was to better understand what happens when tre…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC